Biochem/physiol Actions
Vosoritide is a more stable analogue of human C-type natriuretic peptide (CNP). Vosoritide binds to the Natriuretic-Peptide Receptor B (NPR B), which leads to MAPK pathway inhibition and an increased production of Extracellular Matrix. It reduces the achondroplastic phenotype. Vosoritide is approved for treatment of Achondroplasia aged 5 and up.
- UPC:
- 51434301
- Condition:
- New
- Availability:
- 3-5 Days
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- MPN:
- SML3344-1MG